Utilization of intravenous thrombolysis in 3-4.5 hours: Analysis of the Minnesota stroke registry

Cerebrovascular Diseases

Volumn 34, Issue 5-6, 2012, Pages 400-405

  Tekle, Wondwossen G ^a   Chaudhry, Saqib A ^a   Hassan, Ameer E ^a   Peacock, James M ^b   Lakshminarayan, Kamakshi ^a,b   Tsai, Albert ^b   Luepker, Russell ^a,b   Anderson, David C ^a   Qureshi, Adnan I ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b MINNESOTA DEPARTMENT OF HEALTH   (United States)

Author keywords

Intravenous thrombolysis; Ischemic stroke; Recombinant tissue plasminogen activator

Indexed keywords

ALTEPLASE;

AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; DISEASE REGISTRY; EMERGENCY WARD; ENDOVASCULAR SURGERY; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADMINISTRATION, INTRAVENOUS; AGED; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MINNESOTA; REGISTRIES; STROKE; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; UNITED STATES;

EID: 84870310809     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000343504     Document Type: Article

References (21)

1. Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, Brott T, Frankel M, Grotta JC, Haley EC Jr, Kwiatkowski T, Levine SR, Lewandowski C, Lu M, Lyden P, Marler JR, Patel S, Tilley BC, Albers G, Bluhmki E, Wilhelm M, Hamilton S, ATLANTIS Trials Investigators, ECASS Trials Investigators, NINDS rt-PA Study Group Investigators: Association of outcome with early stroke treatment: Pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004; 363: 768-774.
2. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, et al: Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995; 274: 1017-1025.
3. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, et al: Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998; 352: 1245-1251. (Pubitemid 28470336)
4. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581-1587.
5. Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S: Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 h after symptom onset - the ATLANTIS study: A randomized controlled trial. JAMA 1999; 282: 2019-2026.
6. Clark WM, Albers GW, Madden KP, Hamilton S: The rt-PA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g): Results of a double-blind, placebo-controlled, multicenter study. Stroke 2000; 31: 811-816. (Pubitemid 30198420)
7. Maiser SJ, Georgiadis AL, Suri MF, Vazquez G, Lakshminarayan K, Qureshi AI: Intravenous recombinant tissue plasminogen activator administered after 3 h following onset of ischaemic stroke: A metaanalysis. Int J Stroke 2011; 6: 25-32.
8. Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D, ECASS Investigators: Thrombolysis with alteplase 3 to 4.5 h after acute ischemic stroke. N Engl J Med 2008; 359: 1317-1329.
9. Wahlgren N, Ahmed N, Dávalos A, Hacke W, Millán M, Muir K, Roine RO, Toni D, Lees KR, SITS Investigators: Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): An observational study. Lancet 2008; 372: 1303-1309.
10. Del Zoppo GJ, Saver JL, Jauch EC, Adams HP Jr: Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: A science advisory from the American Heart Association/ American Stroke Association. Stroke 2009; 40: 2945-2948.
11. Shobha N, Buchan AM, Hill MD: Thrombolysis at 3-4.5 hours after acute ischemic stroke onset - evidence from the Canadian Alteplase for Stroke Effectiveness Study (CASES) registry. Cerebrovasc Dis 2010; 31: 223-228.
12. Ahmed N, Wahlgren N, Grond M, Hennerici M, Lees KR, Mikulik R, Parsons M, Roine RO, Toni D, Ringleb P, SITS investigators: Implementation and outcome of thrombolysis with alteplase 3-4.5 h after an acute stroke: An updated analysis from SITS-ISTR. Lancet Neurol 2010; 9: 866-874.
13. Pervez MA, Silva G, Masrur S, Betensky RA, Furie KL, Hidalgo R, et al: Remote supervision of IV-tPA for acute ischemic stroke by telemedicine or telephone before transfer to a regional stroke center is feasible and safe. Stroke 2010; 41:e18-e24.
14. Suzuki S, Saver JL, Scott P, Jahan R, Duckwiler G, Starkman S, et al: Access to intraarterial therapies for acute ischemic stroke: An analysis of the US population. AJNR Am J Neuroradiol 2004; 25: 1802-1806. (Pubitemid 44123711)
15. Wattigney WA, Croft JB, Mensah GA, Alberts MJ, Shephard TJ, Gorelick PB, Nilasena DS, Hess DC, Walker MD, Hanley DF Jr, Shwayder P, Girgus M, Neff LJ, Williams JE, LaBarthe DR, Collins JL, Paul Coverdell National Acute Stroke Registry: Establishing data elements for the Paul Coverdell National Acute Stroke Registry: Part 1: Proceedings of an expert panel. Stroke 2003; 34: 151-156. (Pubitemid 36070816)
16. Minnesota Stroke Registry: Case definition and case identification protocol website. http://www.mnstrokeregistry.org/documents/ MSRCaseDefinitionandIdentification110113. pdf (accessed July 20, 2011).
17. Manual - The Joint Commission. Performance Measurement (PM), IV Thrombolytic Therapy, 2009. http://www.jointcommission. org/standards- information/jcfaq. aspx?ProgramId=47 (accessed July 20, 2012).
18. Tekle WG, Chaudhry SA, Hassan AE, Rodriguez GJ, Suri FK, Vazquez G, et al: Utilization and outcomes of intravenous thrombolysis in expanded time window (3-4.5 h) in general practice with concurrent availability of endovascular treatment. J Vasc Interv Neurol 2012; 5: 22-26.
19. Qureshi AI, Kirmani JF, Sayed MA, Safdar A, Ahmed S, Ferguson R, Hershey LA, Qazi KJ, Buffalo Metropolitan Area and Erie County Stroke Study Group: Time to hospital arrival, use of thrombolytics, and in-hospital outcomes in ischemic stroke. Neurology 2005; 64: 2115-2120. (Pubitemid 40881004)
20. Fang J, Yan W, Jiang GX, Li W, Cheng Q: Time interval between stroke onset and hospital arrival in acute ischemic stroke patients in Shanghai, China. Clin Neurol Neurosurg 2011; 113: 85-88.
21. Schwamm LH, Fonarow GC: Thrombolysis 3 to 4.5 h after acute ischemic stroke. N Engl J Med 2008; 359: 2840, author reply 2841.